Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2552-2026

INZONE DETACHMENT SYSTEM, REF: M00345100950 Recall

INZONE DETACHMENT SYSTEM, REF: M00345100950

FDA recall Class II

Ongoing

FDA lists this Class II recall for INZONE DETACHMENT SYSTEM, REF: M00345100950. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2552-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Apr 6, 2026
FDA report date
Jul 1, 2026
Quantity in commerce
44,937
Distribution
See key details
FDA cause
Component design/selection

What is being recalled?

INZONE DETACHMENT SYSTEM, REF: M00345100950

Affected model & UDI checker

Search the exact identifiers published for Z-2552-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
M00345100950INZONE DETACHMENT SYSTEM, REF: M00345100950Check source noticeNot specified
Not specifiedINZONE DETACHMENT SYSTEM, REF: M00345100950Check source notice04546540697950
FDA code information

UDI-DI: 04546540697950. Lots: WMP133638, WMP133871, WMP133872, WMP133988, WMP133989, WMP134016, WMP134132, WMP134133, WMP134234, WMP134235, WMP134255, WMP134256, WMP134380, WMP134381, WMP134432, WMP134433, WMP134518, WMP134519, WMP134609, WMP134610, WMP134794, WMP134795, WMP134939, WMP134940, WMP135187, WMP135243, WMP135302, WMP135314, WMP135354, WMP135355, WMP135387, WMP135417, WMP135473, WMP135475, WMP135491, WMP135492, WMP135623, WMP135720, WMP135727, WMP135807, WMP135865, WMP135897, WMP136084, WMP136107, WMP136190, WMP136200, WMP136611, WMP136642, WMP136736, WMP136748, WMP136852, WMP136894, WMP136985

View the original FDA recall notice

Why was this product recalled?

Embolization coil detachment system devices may experience premature battery drain causing devices to: 1) Not power on; 2) Power on with faint audible and visual indicators; 3) Be unable to detach a coil as intended, which may necessitate medical intervention if the procedure must be completed with an alternative technique.

What actions did Stryker Neurovascular take?

On 4/3/2026, recall notices were mailed to Supply Chain Management and Recall Coordinators who were asked to do the following: 1) Segregate the affected devices in a secure location for return to recalling firm. 2) If any of the subject devices have been distributed to other organizations, please forward a copy of this notice to the new users and provide contact details to recalling firm so new recipients can be informed appropriately. 3) Maintain awareness of this communication internally until all required actions have been completed within your facility. 4) Complete and return the Business Reply Form via email to nvfieldactions@stryker.com For any additional information or questions, please contact nvfieldactions@stryker.com or US Customer Service: 1-855-91-NEURO (1-855-916-3876), Email: NVCustomerCare@stryker.com

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology